Browsing by Author "Colovic, Milica D. (21639151700)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia(2012) ;Colovic, N. (6701607753) ;Tomin, D. (6603497854) ;Vidovic, A. (6701313789) ;Tosic, N. (15729686900) ;Atkinson, H.D. (7101883648)Colovic, Milica D. (21639151700)Central nervous system (CNS) involvement in acute promyelocytic leukemia (APL) is rare and tends to be seen mostly following treatment with all-trans retinoic acid (ATRA), due to prolonged patient survival and poor penetration of the drug in the CNS. At least 10% of extramedullary relapses in APL involve the CNS, and associated factors include an increased age, the BCR isoform, the development of differentiation syndrome, a high white cell count at presentation and hemorrhage into the CNS during induction therapy. We present the case of a patient with high-risk APL, CD56+, CD2+ in whom a CNS relapse was diagnosed through the presence of a PML/RARα rearrangement on PCR of the cerebrospinal fluid (CSF). © 2011 Springer Science+Business Media, LLC. - Some of the metrics are blocked by yourconsent settings
Publication Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia(2012) ;Colovic, N. (6701607753) ;Tomin, D. (6603497854) ;Vidovic, A. (6701313789) ;Tosic, N. (15729686900) ;Atkinson, H.D. (7101883648)Colovic, Milica D. (21639151700)Central nervous system (CNS) involvement in acute promyelocytic leukemia (APL) is rare and tends to be seen mostly following treatment with all-trans retinoic acid (ATRA), due to prolonged patient survival and poor penetration of the drug in the CNS. At least 10% of extramedullary relapses in APL involve the CNS, and associated factors include an increased age, the BCR isoform, the development of differentiation syndrome, a high white cell count at presentation and hemorrhage into the CNS during induction therapy. We present the case of a patient with high-risk APL, CD56+, CD2+ in whom a CNS relapse was diagnosed through the presence of a PML/RARα rearrangement on PCR of the cerebrospinal fluid (CSF). © 2011 Springer Science+Business Media, LLC.
